Limited data concerning the diagnostic and prognostic value of blood-derived biomarkers in
heart failure with mildly reduced ejection fraction (HFmrEF) is available. This study …

This study investigates the prognostic value of cardiac troponin I (cTNI) and N-terminal pro-B-
type natriuretic peptide (NT-proBNP) levels in patients with cardiogenic shock (CS). Data …

This study investigates the prognostic value of the aspartate-to-alanine aminotransferase
ratio (ie, AST/ALT ratio) and bilirubin in patients with cardiogenic shock (CS). Despite …

Background The outcomes of patients with acute myocardial infarction complicated by
cardiogenic shock (AMI-CS) and the efficacy and safety of extracorporeal life support (ECLS) …

Objective The study investigates the characteristics and prognostic impact of different heart
failure (HF) etiologies in patients with heart failure with mildly reduced ejection fraction …

Background The spectrum of patients with cardiogenic shock (CS) has changed significantly
over time. CS has become especially more common in the absence of acute myocardial …

Background Current data on post-discharge mortality and rehospitalization is still insufficient
among in-hospital survivors of cardiogenic shock (CS), including acute myocardial infarction …

The article explores the prognostic significance of D-dimer and hemoglobin levels in
patients with cardiogenic shock (CS), regardless of its etiology. The study, based on the" …

The aim of the study was to determine the risk factors for the occurrence of acute heart
failure (AHF) of high degrees (Killip classes III and IV) among patients with myocardial …